• Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Consensus Rating of "Hold" from Analysts

    Source: Buzz FX / 23 Nov 2024 02:26:10   America/Chicago


    Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Consensus Rating of "Hold" from Analysts Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Sage Therapeutics, Inc. ( NASDAQ:SAGE - Get Free Report ) has been given an aver
    Read more...
Share on,